Cyteir Therapeutics, Inc. (CYT) Social Stream



Cyteir Therapeutics, Inc. (CYT): $3.04

0.05 (+1.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CYT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

Cyteir Therapeutics Inc (CYT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Cyteir Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 4 $40 $23 $31.5 $3.77 735.54%
2022-01-31 4 $40 $14 $26.75 $3.77 609.55%
2022-02-07 5 $40 $14 $24.6 $3.77 552.52%
2022-03-17 5 $30 $14 $20.6 $3.77 446.42%
2022-03-22 5 $30 $14 $19.8 $3.77 425.2%

The Trend in the Analyst Price Target


Over the past 123 days, CYT's average price target has gone down $11.7.

CYT reports an average of 144.04% for its upside potential over the past 36 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-15 NA 40 23 32.00 19.12 67.36%
2021-08-28 NA 40 23 31.50 18.45 70.73%
2021-09-04 NA 40 23 31.50 20.53 53.43%
2022-01-31 4 40 14 26.75 6.08 339.97%
2022-03-22 5 30 14 19.80 4.58 332.31%

CYT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.1 4 1 0 0 0 5

The Trend in the Broker Recommendations


CYT's average broker recommendation rating improved by 0 over the prior 28 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CYT as an investment opportunity.

  • Cyteir Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 580.11% of all US stocks.
  • Cyteir Therapeutics Inc's variance in analysts' estimates is lower than -419.28% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, Cyteir Therapeutics Inc's number of analysts covering the stock is greater than 192.92% of them.
  • Cyteir Therapeutics Inc's average analyst price target is higher than 237.94% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Cyteir Therapeutics Inc are CYCN, CYBN, and CYAD.

Is CYT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4349 seconds.